Acute Radiation Syndrome: Developing Drugs for Prevention and Treatment; Guidance for Industry; Draft Guidance
FDA-2023-D-1146-0002Other
Comments
7
Last activity Dec 12, 2024
Deadline
Closed on Jul 20, 2023
Closed Jul 20, 2023
Net supportiSupport minus oppose · campaigns included
—
Document
Details
The document's own metadata, straight from the source system.
- Title
- Acute Radiation Syndrome: Developing Drugs for Prevention and Treatment; Guidance for Industry; Draft Guidance
- Posted
- Apr 20, 2023
- Comment period
- Apr 20, 2023 – Jul 20, 2023
- Topics
Analysis
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Include campaigns
Analyzed 0 of 7 comments
0%· analysis in progress
Stance breakdown
—
Net support
Not yet analyzed7
Who commented
Breakdown by commenter type.
Not yet analyzed
7
Comments over time
Weekly arrivals, stacked by stance.
Posted Apr 20, 2023Deadline Jul 20, 2023
May 22Jun 26Jul 10Jul 17Dec 9
Support0Oppose0Other0
Issues raised
The docket's canonical issues. Select one to browse its comments.
Issues are identified as comment analysis progresses — nothing tagged on this document yet.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
Filter:
- Dec 12, 2024Comment from Mitchell BergerAnalysis pending📎 AttachmentRead comment →
- Jul 19, 2023Comment from National Strategic Research Institute (NSRI)Analysis pending📎 AttachmentRead comment →
- Jul 18, 2023Comment from A-Plus-Consulting LLCAnalysis pending📎 AttachmentRead comment →
- Jul 18, 2023Comment from Biomedical Advanced Research and Development Authority (BARDA)Analysis pending📎 AttachmentRead comment →
- Jul 10, 2023Comment from American Academy of Clinical Toxicology (AACT): Radiation SectionAnalysis pending📎 AttachmentRead comment →
- Jun 28, 2023Comment from NIHAnalysis pending📎 AttachmentRead comment →
- May 25, 2023Comment from Larry DeWerdAnalysis pending📎 AttachmentRead comment →